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Poor bioavailability has been reported as a major challenge in the development of curcumin as a pharmaceutical
agent. However, co-administration of curcumin with piperine has been shown to improve curcumin bioavail-
ability. Therefore, to assure product control quality, an analytical method needs to be developed for the deter-
mination of curcumin and piperine content in a dosage form formulation. The objective of this study was to
develop a simple isocratic reversed-phase HPLC (RP-HPLC) method to simultaneously quantify curcumin and
piperine content in solid dispersion based microparticle formulation containing Curcuma longa and Piper nigrum
extracts. The method was validated according to the International Council for Harmonization (ICH) guideline.
Chromatographic separation of three curcuminoids and piperine could be achieved using acetonitrile-methanol-
water of 65:5:35 %, at a flow rate of 1 mL/min and a wavelength of 353 nm for detection. Resolution (Rs) of 3.57
and 1.68 for piperine and curcumin, respectively, a theoretical plate number (N) > 8000 and a tailing factor (T) <
1.5 indicate a satisfactory separation of the compounds. The calibration curve was linear from 1.25-15 μg/mL and
2.5–30 μg/mL for piperine and curcumin, respectively, with the correlation coefficient of >0.999. The intra-day/
inter-day accuracy and precision demonstrated a recovery of 99.54–101.50%/99.38–99.89% and
100.78–102.51%/101.15–102.47% with a Relative Standard Deviation (RSD) of 0.53–0.95%/0.13–1.44 % and
0.28–1.62%/0.46–1.14% for piperine/curcumin. The limit of detection (LOD) were 0.27 and 0.42 μg/mL, for
piperine and curcumin, which reveals an adequate sensitivity. A solid dispersion based microparticle formulation
containing C. longa and P. nigrum extracts confirmed the validity of the developed method as a recovery of 91.14%
and 99.14% for piperine and curcumin, respectively. In conclusion, all the tested parameters confirm the preci-
sion, accuracy, and reliability of the method for the simultaneous analysis of curcumin and piperine within a
microparticle formulation containing C. longa and P. nigrum extracts.1. Introduction
Curcumin, a yellow polyphenolic compound isolated from turmeric
(Curcuma longa) rhizome, has been claimed as a therapeutic agent for
numerous diseases due to its anti-oxidant and anti-inflammatory prop-
erties [1, 2, 3]. However, despite extensive in-vitro and in-vivo studies, a
clear therapeutic effect of curcumin in clinical studies has not been found
yet [4]. These disappointing results can be ascribed to the poor
bioavailability of the compound after oral intake. There are two reasons
for the poor absorption of curcumin; 1) It exhibits a very low aqueous).
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vier Ltd. This is an open access arsolubility of only 11 ng/mL [4, 5], and 2) It is rapidly metabolized [1].
Therefore, a combination of two strategies addressing poor solubility and
rapid metabolism is required.
An often-applied strategy to improve the dissolution behavior of a
poorly water-soluble drug is formulating it as a solid dispersion [6].
Furthermore, piperine (Figure 1d), an alkaloid compound of black pep-
per (P. nigrum) extract has been identified as a bio-enhancer of various
drugs, by stimulating gut amino acid transporters and inhibiting
drug-metabolizing enzymes to improve drug absorption, bioavailability,
and bio-efficacy [7]. Both strategies are thought to be useful to be appliedMarch 2021
ticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
Figure 1. Molecular structure of (a) curcumin; (b) demethoxycurcumin; (c) bis-demethoxycurcumin; (d) piperine.
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technology containing C. longa and P. nigrum extracts to improve the
bioavailability of curcumin. In this study, we will focus on solid disper-
sion microparticles prepared by spray drying using polyvinylpyrrolidone
K30 (PVP K30) as a carrier.
During pre-formulation, the quality control of the product needs to be
addressed. Determining compounds in the final product is a part of
quality assurance in production processes. Therefore, the amount of
curcumin and piperine containing in the microparticle needs to be
determined accurately.
Several analytical methods for the quantification of curcumin and
piperine have been developed, however, the majority of these methods
concern the quantification of curcumin and piperine individually [8, 9, 10,
11]. A few methods have been developed to simultaneously determine
curcumin and piperine. A spectroscopic method combining with the appli-
cation of Vierordt's equation was successfully applied to allow the deter-
mination of curcumin and piperine as a mixture of C. longa and P. nigrum
extracts in dissolution medium [12], however, the method is not selective.
HPLC with UV-Vis detection is one of the most common techniques
used in the analysis and quality control of several formulations con-
taining curcumin or piperine and in biological samples. Moorthi et al.
validated an isocratic HPLC method to allow curcumin and piperine
quantification in a Eudragit based nanosuspension containing pure cur-
cumin and piperine as a binary mixture [13]. Furthermore, Sethi et al.
reported a selective and specific HPLC method for simultaneous esti-
mation of curcumin and piperine in human plasma [14]. Also, a sensitive
LC/MS method was developed to enable simultaneous quantification of
curcumin and piperine for pharmacokinetic evaluation [15]. Although
the HPLC methods have been reported to be useful to simultaneously
analyze curcumin and piperine in various samples, the developed
methods were applied to determine curcumin and piperine as pure
compounds in the samples.
To our best knowledge, no HPLC analytical method has been reported
for the simultaneous analysis of curcumin and piperine in extracts. It
should be emphasized that commercially available curcumin originating
from turmeric rhizome is usually composed of a mixture of naturally
occurring curcuminoids, namely curcumin, demethoxycurcumin, and bis-
demethoxycurcumin (Figure 1a, b, c). This mixture of compounds could
easily interfere with chromatographic separation if not properly resolved.
Therefore, the study aimed to develop a validated HPLC method to
simultaneously quantify curcumin and piperine in solid dispersion-based
microparticle formulation containing C. longa and P. nigrum extracts.
2. Materials and methods
2.1. Materials
Bis-demethoxycurcumin, demethoxycurcumin, curcumin, and
piperine reference standards with a purity of>98%were purchased from2
Sigma-Aldrich (St. Louis, USA). C. longa extract of high curcuminoids
content (97.56%) was a kind gift from PT Phytochemindo Reksa, Bogor,
Indonesia. P. nigrumwas extracted and purified as described by Saha et al.
[16]. Polyvinylpyrrolidone K30 (PVP K30) was kindly given by PT
Konimex, Solo, Central Java, Indonesia. Ethanol, HPLC grade acetoni-
trile, HPLC grade methanol, and analytical grade phosphoric acid were
purchased from Merck (Darmstadt, Germany). A PTFE filter with a pore
size of 0.22 μmwas obtained fromWhatman. Milli-Q water was prepared
in the laboratory.
2.2. Preparation of solid dispersion based microparticle formulation and
characterization
A PVP-30 based solid dispersion containing 30 w/w % C. longa extract
and10w/w%P. nigrum extractwas preparedby spraydrying. Inbrief, 1800
mg C. longa extract and 600mg P. nigrum extract were dissolved in 400mL
ethanol and 3600 mg of PVP K30 was dissolved in 50 mL ethanol. The two
solutions were mixed for approximately 15 min using a magnetic stirrer.
The resulting solution was fed into a BUCHI B-290 mini spray dryer
equipped with a B-295 dehumidifier via a two-way channel with a nozzle
diameter of 0.7 mm. Drying was conducted at an inlet temperature of 105
C, aspiration of 100%, feeding rate of 20%, and an atomization pressure
of 500 Ln/h. The outlet temperature was observed at 60–65 C. Micro-
graphs of the microparticles were taken using a scanning electron mi-
croscope (Hitachi TM 3000, Japan).
2.3. Method development
2.3.1. Finding the detection wavelength
Individualmethanolic solutions of curcumin (15 μg/mL) and piperine (5
μg/mL) were scanned at the range of 315–450 nm using a UV-Vis spectro-
photometer (Shimadzu, Japan). The detection wavelength for the simulta-
neous analysis of curcumin and piperine was selected based on the crossing
point of the curcumin and piperine spectra of the spectral overlay.
2.3.2. HPLC instrument and conditions
HPLC analysis was carried out using a Shimadzu LC 2010HT HPLC
system (Shimadzu, Kyoto, Japan) equipped with a serial dual plunger
pump, an autosampler, and an SPD-20A/20AV series UV-Vis detectors.
LC-solution software was used for peak integration. Chromatographic
separation was achieved on a C18 column (250 4.6 mm, Eurospher 100
with 5 μm) equipped with a pre-column (Knauer, Berlin, Germany). The
mobile phase was filtered through a 0.22 μm filter and degassed by
ultrasonication before use. The injection volume was 20 μL. The column
temperature was kept at 33 C during chromatographic operation.
2.3.3. Selection of mobile phase
The aim was to find a mobile phase composition, which provides an
acceptable peak separation of multiple components i.e. curcuminoids
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with a short running time of less than 10 min. A sample consisting of a
mixture of 10 μg/mL C. longa and 5 μg/mL P. nigrum extracts in meth-
anolic solution was used to evaluate mobile phases of different
compositions.
Peak identification was carried out by running standard solutions at
accordingly used mobile phase compositions. The mobile phase com-
positions were evaluated on the chromatographic separation parame-
ters i.e. tailing factor (T), peak resolution (Rs), and theoretical plate
number (N). The acceptance criteria are T < 2, Rs > 1.5 and N > 2000
[17].
2.3.4. Preparation of stock and calibration solutions
Stocks of standard solution of curcumin and piperine at a final con-
centration of 1 mg/mL were prepared by dissolving an appropriate
amount of curcumin and piperine in methanol as an individual solution.
All solutions were prepared in light-protected vials to ensure the stability
of curcumin and piperine [18].
2.4. Method validation
The developed method was validated as per Q2R1 ICH guidelines
[19] including selectivity, system suitability, accuracy, precision, limit of
detection (LOD), limit of quantification (LOQ), linearity, and robustness.
2.4.1. System suitability
Six replicate injections of the sample containing a mixture of curcu-
min and piperine at a concentration of 10 and 5 μg/mL in the methanolic
solution were simultaneously analysed. Retention time (Tr), peak area
(AUC), Rs, T, and N were determined. Relative standard deviation (RSD)
values of these parameters were calculated to evaluate the system suit-
ability of the developed method. The suitability test was accepted when
the RSD values of these parameters were less than 2%.
2.4.2. Specificity and selectivity
Specificity refers to the ability of a method to distinguish between the
compound(s) of interest and impurity present in the sample matrix [20].
For the specificity study, the chromatogram of blank samples originated
from the formulation matrix (no drugs) was compared to the chro-
matogram of microparticle formulation containing C. longa and P. nigrum
extracts. Selectivity is the ability of the method to clearly show separa-
tion between the different peaks. A value of Rs > 1.5 is required to
confirm the method to be sufficiently selective [20].
2.4.3. Preparation of calibration solutions of curcumin and piperine and
linearity
Calibration solutions were prepared using solutions of curcumin and
piperine in methanol at different concentrations. Stock solutions of cur-
cumin and piperine were diluted with methanol and mixed to obtain
samples with curcumin concentrations of 0.05–45 μg/mL and piperine
concentrations of 0.025–20 μg/mL for. Linearity between concentration
and peak area was tested using the regression line as provided by the
least square analyses. The correlation coefficient (r) was used to judge
linearity [21]. The concentration range with an r > 0.99 was considered
linear. The limit of detection (LOD) and the limit of quantification (LOQ)
were determined using the standard deviation approach [20]. To do so,
serially diluted concentrations of the calibration solutions were prepared
at nearly targeted LOD or LOQ and analyzed using least square analysis.
The standard deviation (SD) of the y-intercept and slope were deter-
mined with which the LOD and LOQwere calculated based on Eq. (1) and
Eq. (2) below [22].
LOD¼ 3:3 x SD=slope (1)LOQ¼ 10 x SD=slope (2)3
2.4.4. Accuracy and precision
Accuracy refers to the closeness of the obtained value with that true
value of the corresponding sample concentrations, while precision de-
notes the closeness agreement between independent test results obtained
under the developed method. In this study, accuracy and precision were
carried out using the assay sample spiking method. The assay sample was
the microparticle formulation as described in section 2.2; dissolved in
methanol. Themethanolic sample solutions at the concentration of 9.9 μg/
mL (sample weight/volume) were spiked with curcumin and piperine
stock solutions to result in a mixture of final addition concentrations of
2.50; 15.00; 30.00 and 1.25; 7.50; 15.00 μg/m for curcumin and piperine.
Accuracy was evaluated based on the recovery percentage, and pre-
cision was studied using repeatability assay based on the RSD values of
three different sample concentrations. Accuracy and precision were
conducted on one-day analysis (intra-day) and three consecutive days
(inter-day) of freshly prepared samples. The analysis was done in tripli-
cate for each concentration level. The degree of accuracy and precision
were judged according to the Association of Official Analytical Chemists
requirement [21].
2.4.5. Robustness
The robustness of a developed analytical method refers to its ability to
remain unaffected by deliberate changes of the chromatographic condi-
tions which indicates its reliability during normal usage. Peaks retention
time and AUC values of curcumin and piperine resulted from the changed
parameters of mobile phase composition, flow rates, and detection
wavelengths were analyzed for the RSD values. The RSD value of less
than 2% is an indication of a robust method.
2.4.6. Assay of curcumin and piperine in the microparticle formulation
A 200 mg of the microparticle formulation was accurately weighed
and dissolved in 50 mL of methanol in a volumetric flask. The solution
was subjected to ultrasonication for 5 min. The solution was diluted 100
times with methanol to achieve a final concentration of 40 μg/mL and
then analyzed by HPLC. The content of curcumin and piperine was
calculated based on the calibration curve constructed as described in
section 2.4.3.
2.5. Data analysis
A Least Square Analysis supported by Excel Microsoft INC USA was
used to analyze the linearity of the calibration curve. Mean and standard
deviation was calculated using Excel Software (Microsoft Inc, USA).
3. Results and discussion
3.1. Preparation of solid dispersion based microparticle formulation and
characterization
Microparticles of PVP-30 based solid dispersion containing curcu-
minoids of C. longa and piperine of P. nigrum extracts could be success-
fully prepared by spray drying as can be seen in the scanning electron
microscopic images (see example in Figure 2).
3.2. Finding the detection wavelength
The spectral scanning of a single methanolic solution of curcumin and
piperine is shown in Figure 3. As shown in Figure 3, the methanolic so-
lution of curcumin (15 μg/mL) absorbed wavelength at the maximum
value of 425 nm, while piperine dissolved in methanol at the concen-
tration of 5 μg/mL showed a maximum absorption at the wavelength of
342 nm. Both compounds exhibited an overlapping absorption area at
around 315–360 nm, where curcumin and piperine can be simulta-
neously detected.
Figure 2. Scanning electron microscopic image of the spray dried PVP K30
based solid dispersion containing curcuminoids and piperine.
Figure 3. The overlay spectra of curcumin (15 μg/ml) and piperine (5 μg/ml) in
methanolic solution.
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Therefore, this wavelength was used for the simultaneous detection of
curcumin and piperine in this study.Table 1. Mobile phase compositions and the observed peak characteristics.
Code ACN MeOH water Curcuminoids
BDMC DMC
Tr Rs T Tr
1 30 25 45 - - - 6.30
2 40 30 30 8.09 1.55 0 8.25
3 30 50 20 4.26 5.61 1.11 4.86
4 60 10 30 5.03 6.11 1.06 5.38
5 65 5 30 4.82 4.74 0.95 5.18
Note:
1. ACN ¼ acetonitrile; MeOH ¼ methanol.
2. BDMC ¼ bis-demethoxycurcumin; DMC ¼ demethoxycurcumin; C ¼ curcumin.
4. Tr ¼ retention time; Rs ¼ resolution; T ¼ tailing factor.
5. - ¼ not detected.
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3.3. Selection of mobile phase
3.3.1. The use of methanol and acetonitrile
Simultaneous analysis of a mixture contains weak acids and weak
basics drugs on anRPHPLC is always challenging [23]. The target analytes
in this study are curcumin (weak acid) and piperine (weak basic) which
are present as co-mixture with other curcuminoids compounds (bis-de-
methoxycurcumin, demethoxycurcumin) as the active components in the
microparticle formulation. The combinations methanol-water and
acetonitrile-water are the most commonly used solvent mixtures in RP
HPLC analysis. However, curcuminoids are poorly resolved in
methanol-water mixtures at a volume ratio of 50:50 and 60:40 with
calculated polarity index of 7.55 and 7.06. Methanol was therefore
replacedby acetonitrile. Althoughwith an acetonitrile-water volume ratio
of 60:40 (polarity index of 7.48) a sharp peak was obtained, all three
curcuminoids were co-eluted at a retention time of 12.54 min.
3.3.2. The effect of 0.1% phosphoric acid as pH modifier
A study by Espinosa et al. revealed that the retention time of acidic
and basic compounds is strongly dependent on the pH of the mobile
phase [24]. The addition of acid into the mobile phase can improve peak
separation and reduce peak tailing by modification of interaction be-
tween the target analyte and the stationary phase of the HPLC column
[25, 26].
Therefore, a mobile phase composition as reported by Sethi et al.,
which was used to simultaneously analyze curcumin and piperine in the
plasma sample [14], with slight modifications was evaluated. The mobile
phase consisted of acetonitrile-methanol-water-phosphoric acid 0.1% at
a volume ratio of 20:30:47.5:2.5 (pH 4.0) and was delivered at 1 mL/min
in an isocratic mode. However, under these conditions, the three cur-
cuminoids compounds were co-eluted at a retention time of 11.80 min,
whereas no piperine peak appeared within a running time of 15 min,
while a maximum running time of 10 min was aimed for. To evaluate the
behavior of the weakly basic compound (piperine) at a lower pH, the
composition of the mobile phase was adjusted to
acetonitrile-methanol-phosphoric acid 0.1 % at a volume ratio of
20:30:50 (pH 3.0) and a calculated polarity index of 7.79. However, a
peak in the chromatogram that can be assigned to piperine remained
absent during a run time of 15 min. Remarkably, when the mobile phase
polarity was slightly modified by replacing the methanol with acetoni-
trile to result in a calculated polarity index of 8.00 of the mobile phase
compositions of acetonitrile-water-phosphoric acid 0.1% at a volume of
50:47.5:2.5 (pH 4.0), piperine was eluted already at 0.516 min.
LoBrutto et al. reported the effect of pH on the retention time of small
basic compounds, aniline, and pyridine on an isocratic HPLCmode. At the
pH rangeof 1.3–8.6of themobile phasewitha compositionof acetonitrile-
water at a volume ratio of 10:90, it was reported that as the pH of the
mobile phase decreased, the retention time of the targeted compounds
increased due to counterion interactions resulted from acidic mobilePiperine
C
Rs T Tr Rs T Tr Rs T
4.66 0 6.63 0.76 0 - - -
1.08 0 8.99 1.14 0 10.72 5.34 1.17
0 0 5.35 0 0.91 8.77 3.66 1.11
1.56 1.20 5.78 1.64 1.18 7.84 3.22 1.08
1.48 1.12 5.58 1.68 1.16 7.91 3.57 1.06
Figure 4. Chromatographic separation of bis-demethox-
ycurcumin (BDMC), demethoxycurcumin (DMC), curcumin
(C) and piperine (P) after injection of 20 μL of the sample
containing 10 μg/mL C. longa and 5 μg/mL P. nigrum ex-
tracts. Separation was carried out using a Knauer C18
column (250  4.6 mm, Eurospher 100 with 5 μm)
equipped with a pre-column and an isocratic mobile phase
composed of an acetonitrile-methanol-water mixture with
a volume ratio of 65:5:30 at flow rate of 1 mL/min and a
detection wavelength of 353 nm.
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agent trifluoroacetic acid on the retention of fourweakly basic derivatives
of triazole with different pKa values [28]. Using mixtures of water and
acetonitrile as themobile phase in the gradientmode, itwas found that the
lower the degree of protonation, the shorter the retention time. As phos-
phoric acid is also categorized as a chaotropic agent [29], it is presumable
that the absence of piperine during 15min running in this study using the
mobile phase composition of acetonitrile-methanol-water-phosphoric
acid 0.1% at a volume ratio of 20:30:47.5:2.5 (pH 4.0) and
acetonitrile-methanol-phosphoric acid 0.1% at 20:30:50 (pH 3.0) might
be attributed to the effect of chaotropic effect resulting partially proton-
ated piperine, making piperine molecules interact with the stationary
phase. However, when methanol was replaced by acetonitrile, a solvent
with higher elution strength than methanol at the mobile phase compo-
sition of acetonitrile-water-phosphoric acid 0.1% of 50:47.5:2.5 (pH 4.0),
the previous interaction of piperine with the stationary phase might be
changed, inwhichpiperinemight bemore solvated in themobile phase.As
a result, piperine was eluted at an early retention time of 0.516 min.
Based on the observation that the exchange of methanol by acetoni-
trile in the mobile phase and the presence of phosphoric acid had a
dramatic effect on the retention time of piperine, various acetonitrile-
methanol-water ratios without phosphoric acid were evaluated. In
these experiments, phosphoric acid was not included in the mobile phase
as acids can substantially reduce the life-time of the column. The effects
of the mobile phase composition on peak retention (Tr), peak resolution
(Rs), and peak tailing factor (T) are shown in Table 1.
When scrutinizing this table, it can be concluded that the optimal
mobile phase composition consisted of an acetonitrile-methanol-water
mixture with a volume ratio of 65:5:30, which corresponds to the
calculated polarity index of 7.08. Figure 4 shows the resulting baseline
chromatographic separation of bis-demethoxycurcumin, demethox-
ycurcumin, curcumin, and piperine of the methanolic sample containing
10 μg/mL C. longa and 5 μg/mL P. nigrum extracts. Curcumin was eluted
at 5.58 min with an Rs of 1.68 and a T of 1.16; piperine was eluted at 7.91Figure 5. Chromatographic separation for specificity and selectivity assessment. (a) b
mL); (c) solid dispersion based microparticle (9.9 μg/mL sample) containing C. longa
DMC ¼ demethoxycurcumin.
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min with an Rs of 3.57 and T of 1.06. The obtained values of Rs, T, N of
curcumin and piperine meet the requirements of qualified peak in HPLC
(T < 1.5, Rs > 1.5 and N > 2000 [17,29].
3.4. Specificity and selectivity
The method specificity is represented in Figure 5. There are no peaks
observed at the retention time of curcumin and piperine in the blank
sample (Figure 5a). The retention time for curcumin and piperine in the
microparticle formulation sample (Figure 5c) is following the standard
solution of curcumin and piperine (Figure 5b). The result indicates the
method specificity. The method selectivity is also demonstrated by the
baseline separation parameters obtained for curcumin and piperine at
which the Rs values for curcumin and piperine are larger than 1.5
(Figure 5c). The curcumin peak was distinguishable from the deme-
thoxycurcumin peak with the Rs of 1.6 and T of 1.1. These results confirm
the selectivity of the developed method.
3.5. System suitability test
The optimized HPLC method was subjected to a system suitability
test. A sample was injected six times in the system and the T, N, AUC, Tr,
and Rs were determined. As shown in Table 2, the RSD values of all these
parameters for curcumin as well as piperine were below 2% which in-
dicates all parameters of the proposed HPLC method satisfy the USP and
ICH standards. Therefore, the developed HPLCmethod is concluded to be
suitable and effective for the analysis [17].
3.6. Linearity, range and sensitivity
Calibration curves were acquired by plotting peak area as a function
of the corresponding concentration (Figure 6). Table 3 shows the
regression parameters resulted from the least-square method. As shown
in Figure 6 and Table 3, linearity was confirmed at concentration rangeslank; (b) standard solution containing curcumin (10 μg/mL) and piperine (5 μg/
and P. nigrum. C ¼ curcumin, P ¼ piperine, BDMC ¼ bis-demethoxycurcumin,
Table 2. System suitability test of the developed method.
Injection Tr (min) AUC T Rs N
C P C P C P C P C P
1 5.421 7.660 226134 283307 1.205 1.065 1.624 3.574 8167.5 9561.8
2 5.588 7.914 229048 284215 1.238 1.071 1.649 3.576 8283.6 9356.3
3 5.642 7.970 230929 284790 1.215 1.072 1.680 3.578 8144.9 9243.9
4 5.652 7.994 231654 285454 1.205 1.098 1.690 3.576 8198.7 9409.2
5 5.644 7.974 231274 284831 1.197 1.097 1.688 3.577 8300.8 9474.6
6 5.636 7.977 231993 285380 1.202 1.094 1.690 3.575 8145.6 9353.2
Mean 5.597 7.915 230172 284662 1.210 1.083 1.670 3.576 8206.8 939987
SD 0.089 0.128 2230 803 0.015 0.015 0.027 0.001 69.2 109.8
RSD (%) 1.595 1.614 0.969 0.282 1.221 1.389 1.646 0.040 0.84 1.17
C ¼ Curcumin; P¼Piperine; Tr ¼ retention time; Rs ¼ resolution; T ¼ tailing factor; N ¼ theoretical plate number; AUC ¼ Area Under Curve.
Figure 6. Calibration curves of piperine (a) and curcumin (b) standard following the method developed in this study (n ¼ 3). The series concentrations of calibration
samples were 1.25; 2.50; 5.00; 7.50; 10.00; 12.50; 15.00 μg/mL for piperine and 2.50; 5.00; 10.00; 15.00; 20.00; 25.00; 30.00 μg/mL for curcumin.
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respectively, as the correlation coefficient, r, within these ranges were
higher than 0.999. Also, linearity can be further evaluated by calculation
of the RSD% of the slope values, which did not exceed 2.0 % [30].
Method sensitivity was tested by determining LOD and LOQ. The
calculated LOD of piperine and curcumin was 0.27 μg/mL and 0.42 μg/
mL, respectively, and the calculated LOQ was 0.91 μg/mL and 1.41 μg/
mL for piperine and curcumin, respectively.
3.7. Accuracy and precision
Accuracy and precision studies were conducted according to the ICH
recommendations [19] on three different levels of sample concentrations
which are low, medium, and high of analyte concentration. The three
concentration levels used in this study were 1.25; 7.50; 15.00 and 2.50;
15.00; 30.00 for piperine and curcumin, respectively.
Table 4 summarizes the accuracy and precision data. The results show
the intra-day and inter-day recovery of piperine were between 99.54-
101.50% and 99.38–99.89%, respectively while the intra-day and inter-
day recovery of curcumin reported were between 100.78-102.51% and
101.15–102.47%, respectively. Repeatability and intermediate precision
of the developed method were evaluated by calculating RSD obtained in
one day and 3 different days on freshly prepared samples. As compiled in
Table 4, it is shown that intra-day and inter-day RSD of piperine were
0.53–0.95% and 0.13–1.44%, respectively; intra-day and inter-day RSD
of curcumin were 0.28–1.621% and 0.46–1.14%, respectively.
According to calculated recovery and RSD values, these reported data
(Table 4) show that the recovery and RSD values fully satisfy within the
generally accepted range of AOAC (90–107% recovery and <5.3% of6
RSD) [21], which suggests a high level of accuracy and precision of the
developed method.
3.8. Robustness
The robustness parameters of the developed method were obtained
by investigating the impact of slight changes in the chromatographic
conditions on peak retention time and peak area. Moderate changes in
volume ratios of mobile phase composition (2%), flow rate (0.1 mL/
min), and detection wavelength (2 nm), however, did not significantly
affect the retention time and peak area as indicated by the RSD value of
<2% (see Table 5).
3.9. Application of the developed method
The developed RP-HPLC method was applied to simultaneously
determine the concentration of curcumin and piperine in the micropar-
ticle formulation sample containing multicomponent appears in C. longa
and P. nigrum extracts. The developed method was successfully validated
to separate multi-compounds in the microparticle formulation i.e. cur-
cumin from its curcuminoids family, and piperine (Table 6). As shown in
Table 6, the observed content of curcumin and piperine in the micro-
particles was 22.42 0.67 w/w % and 9.04  0.67 w/w %, respectively.
Using reference standards, it was foundwith the developed HPLCmethod
that C. longa extract contained 75.38 w/w % curcumin and P. nigrum
extract contained 98.97 w/w % piperine. As the claimed percentages of
C. longa and P. nigrum extracts in the microparticles were 30 w/w % and
10 w/w%, respectively, it can be calculated that the theoretical amounts
of curcumin and piperine in the microparticles should be 22.61 w/w %
Table 3. Validation parameters for piperine and curcumin (n ¼ 3).
Parameter Piperine Curcumin
Linearity range (μg/mL) 1.25–15.00 2.50–30.00
Linear equation Y ¼ 140779x þ 11549 Y ¼ 42144x þ 1559.5
Correlation coefficient of (r) 0.9990 0.9994
RSD of slope 1.017 0.784
Limit of Detection (μg/mL) 0.27 0.42
Limit of Quantification (μg/mL) 0.91 1.41
Table 4. Results of intra-day and inter-day accuracy and precision n ¼ 3.
Compound Final concentration (μg/ml) Intra-day Inter-day
Recovered quantity (μg/ml) Recovery (%) RSD (%) Recovered quantity (μg/ml) Recovery (%) RSD (%)
Curcumin 2.50 2.54  0.04 101.49 1.47 2.61  0.02 102.47 0.79
15.00 15.12  0.25 100.78 1.62 15.28  0.17 101.88 1.14
30.00 30.75  0.09 102.51 0.28 31.39  0.14 101.15 0.46
Piperine 1.25 1.27  0.01 101.50 0.95 1.25  0.01 99.79 1.08
7.50 7.47  0.07 99.54 0.94 7.45  0.01 99.38 0.13
15.00 15.21  0.08 101.38 0.53 14.98  0.22 99.89 1.44
Table 5. Robustness test of the developed method (n ¼ 3).
Condition Curcumin Piperine
AUC Tr (min) AUC Tr (min)
mean RSD (%) mean RSD (%) mean RSD (%) mean RSD (%)
Selected mobile phase composition is acetonitrile: methanol: water ¼ 65:5:30 vol-%
60:10:30 vol-% 21273.6 0.72 5.58 0.10 25209.7 0.308 7.84 0.09
70:5:25 vol-% 22796.7 0.54 5.66 0.10 25358.3 0.500 7.95 0.49
Flow rate of 1 mL/min
0.9 mL/min 21320.7 0.32 5.49 0.02 25296.3 0.955 7.83 0.05
1.1 mL/min 21255.7 0.83 5.82 0.43 25164.6 0.501 7.99 0.12
Selected detection wavelength of 353 nm
351 nm 21120.3 1.15 5.61 0.16 325481.6 0.329 7.85 0.63
355 nm 23781.4 0.45 5.63 0.07 252137.6 0.264 7.92 0.17
Tr ¼ retention time; AUC ¼ Area Under Curve.
D. Setyaningsih et al. Heliyon 7 (2021) e06541and 9.90 w/w %, respectively. Using these percentages, it can be calcu-
lated that the recovery of curcumin and piperine from the microparticles
was 99.14% and 91.31%, respectively, using the developed HPLC
method (Table 6).
USP monograph on curcuminoids dosage form requires that the
content of the active compound in the dosage form products should beTable 6. Curcumin and piperine content in microparticles.
Sample Amount found in microparticles









RSD (%) 3.05 7.47
Formulation claim: 30 w/w % C. longa and 10 w/w % P. nigrum extracts.
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between 90.0% and 110.0% [31]. Thus, the curcumin and piperine
content found in the solid dispersion-based microparticle formulation
using the developed method complies with the product specification of
the USP monography. The results from the assay of curcumin and
piperine confirm the successful implementation of the proposed HPLC
method for the simultaneous quantification of curcumin and piperine in
microparticles formulation containingmulticomponent i.e. curcumin and
piperine of C. longa and P. nigrum extracts. Furthermore, as the running
time of HPLC analysis is only 10 min, the proposed method is suitable tobe applied during routine analysis as part of quality control procedures in
the formulation of the microparticles.
4. Conclusion
A suitable, rapid, accurate, and precise RP-HPLC method was
developed for the simultaneous determination of curcumin and piperine
in a solid dispersion-based microparticle formulation. The developed
method offers a linear response across a wide range of analyte con-
centrations with satisfactory method sensitivity. Furthermore, the pro-
posed RP-HPLC method guarantees the extension of the column life-
time and HPLC system due to the absence of acid in the mobile phase
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